Clinical Trials Browser

Chemotherapy, Adjuvant × 30 days × Clear all

NCT05879926 2026-04-02

OFSET

Phase 3 Recruiting

Breast Neoplasms

NCT02676349 2026-03-27

Neoadjuvant mFolfirinox With or Without Preoperative Concomitant Chemoradiotherapy in Patients With Borderline Resectable Pancreatic Carcinoma (PANDAS-PRODIGE 44)

Phase 2 Completed

Gastrointestinal

Pancreatic Neoplasms